- Home
- GREE vs LPTX Comparison
GREE vs LPTX Comparison
Compare GREE & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GREE
- LPTX
- Stock Information
- Founded
- GREE 1937
- LPTX 2011
- Country
- GREE United States
- LPTX United States
- Employees
- GREE N/A
- LPTX N/A
- Industry
- GREE Investment Bankers/Brokers/Service
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GREE Finance
- LPTX Health Care
- Exchange
- GREE Nasdaq
- LPTX Nasdaq
- Market Cap
- GREE 31.7M
- LPTX 35.4M
- IPO Year
- GREE N/A
- LPTX N/A
- Fundamental
- Price
- GREE $1.83
- LPTX $0.42
- Analyst Decision
- GREE
- LPTX Hold
- Analyst Count
- GREE 0
- LPTX 1
- Target Price
- GREE N/A
- LPTX N/A
- AVG Volume (30 Days)
- GREE 320.2K
- LPTX 2.0M
- Earning Date
- GREE 11-07-2025
- LPTX 11-17-2025
- Dividend Yield
- GREE N/A
- LPTX N/A
- EPS Growth
- GREE N/A
- LPTX N/A
- EPS
- GREE N/A
- LPTX N/A
- Revenue
- GREE $59,246,000.00
- LPTX N/A
- Revenue This Year
- GREE N/A
- LPTX N/A
- Revenue Next Year
- GREE N/A
- LPTX N/A
- P/E Ratio
- GREE N/A
- LPTX N/A
- Revenue Growth
- GREE N/A
- LPTX N/A
- 52 Week Low
- GREE $0.58
- LPTX $0.22
- 52 Week High
- GREE $3.84
- LPTX $3.92
- Technical
- Relative Strength Index (RSI)
- GREE 47.62
- LPTX 42.71
- Support Level
- GREE $1.71
- LPTX $0.43
- Resistance Level
- GREE $2.23
- LPTX $0.56
- Average True Range (ATR)
- GREE 0.19
- LPTX 0.06
- MACD
- GREE -0.04
- LPTX -0.02
- Stochastic Oscillator
- GREE 28.57
- LPTX 3.19
About GREE Greenidge Generation Holdings Inc.
Greenidge Generation Holdings Inc owns and operates a vertically integrated cryptocurrency data center. Company operates in three segments: Crypto Mining, Datacenter Hosting, Power and Capacity. The company owns and operates facilities at two locations: the Torrey, New York, and Spartanburg, South Carolina. The cryptocurrency data center operations generate revenue in the form of bitcoin by earning bitcoin as rewards and transaction fees for supporting the bitcoin network with application-specific integrated circuit computers (ASICs or miners) owned or leased by the company.
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.